ISOJASMONE
Relevant Data
Food Additives Approved by WHO:
Flavouring Substances Approved by European Union:
General Information
Mainterm | ISOJASMONE |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 11050-62-7 |
Regnum |
172.515 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 6435841 |
IUPAC Name | 2-methyl-3-[(E)-pent-2-enyl]cyclopent-2-en-1-one |
InChI | InChI=1S/C11H16O/c1-3-4-5-6-10-7-8-11(12)9(10)2/h4-5H,3,6-8H2,1-2H3/b5-4+ |
InChI Key | GVONPEQEUQYVNH-SNAWJCMRSA-N |
Canonical SMILES | CCC=CCC1=C(C(=O)CC1)C |
Molecular Formula | C11H16O |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 164.248 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 3 |
Complexity | 233.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w I A A A A A A A A A A A A A A A A A A A A Q A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A D A S A g A A C A A A A A A C I A q B S A A A A A A A g A A A I C A E A A E g A A B I A A Q A A A A A A g A A I A Q M I i I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 17.1 |
Monoisotopic Mass | 164.12 |
Exact Mass | 164.12 |
XLogP3 | None |
XLogP3-AA | 2.2 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9564 |
Human Intestinal Absorption | HIA+ | 0.9973 |
Caco-2 Permeability | Caco2+ | 0.7864 |
P-glycoprotein Substrate | Non-substrate | 0.5861 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.5077 |
Non-inhibitor | 0.9258 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7765 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5283 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8729 |
CYP450 2D6 Substrate | Non-substrate | 0.8603 |
CYP450 3A4 Substrate | Substrate | 0.5240 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6779 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9211 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9044 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8462 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9533 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6695 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5864 |
Non-inhibitor | 0.8190 | |
AMES Toxicity | Non AMES toxic | 0.9387 |
Carcinogens | Non-carcinogens | 0.7995 |
Fish Toxicity | High FHMT | 0.8291 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8719 |
Honey Bee Toxicity | High HBT | 0.8413 |
Biodegradation | Ready biodegradable | 0.6325 |
Acute Oral Toxicity | III | 0.8085 |
Carcinogenicity (Three-class) | Non-required | 0.6084 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -2.5355 | LogS |
Caco-2 Permeability | 1.4260 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.7903 | LD50, mol/kg |
Fish Toxicity | 0.8641 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.2768 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Carbonyl compounds |
Intermediate Tree Nodes | Ketones |
Direct Parent | Cyclic ketones |
Alternative Parents | |
Molecular Framework | Aliphatic homomonocyclic compounds |
Substituents | Cyclic ketone - Organic oxide - Hydrocarbon derivative - Aliphatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as cyclic ketones. These are organic compounds containing a ketone that is conjugated to a cyclic moiety. |
From ClassyFire